Neo-adjuvant Evaluation of Glioma Lysate Vaccines in WHO Grade II Glioma
Oligodendroglioma Astrocytoma, Grade II Glioma, Astrocytic Glioma Malignant Glioma Oligoastrocytoma, Mixed low-grade glioma WHO grade II vaccine immunotherapy Astrocytoma Poly I-C Carboxymethylcellulose Sodium Poly ICLC GBM6-AD and poly-ICLC before and after surgery GBM6-AD and poly-ICLC after surgery only Vaccines before and after surgery Vaccines after surgery only
Lead Scientists at UC Cancer
- Jennie Taylor, MD (ucsf)
Associate Professor, Neurology. Authored (or co-authored) 20 research publications.
- Hideho Okada, MD, PhD (ucsf)
Dr. Okada is a creative physician-scientist who has developed therapeutic modalities in the laboratory, translated them into clinical protocols, and used his expertise as both scientist and clinician to assess the clinical data from ongoing trials. Dr. Okada's work has consistently focused on immunotherapeutic strategies aimed at a daunting challenge in oncology – malignant brain tumors.
- accepting new patients
- Start Date
- Completion Date
- University of California, San Francisco
- Phase 1
- Study Type
- Last Updated